Abstract
Vancomycin is often used in orthopedic surgery as a local prophylaxis of bacterial infection. The aim of this work was to compare the release of vancomycin and its biologically inactive crystalline degradation products (CDP-1) during in vitro experiments from different types of local antibiotic delivery systems (bone grafts and bone cements). The concentrations of vancomycin and its crystalline degradation products were determined by high-performance liquid chromatography. Each experiment was performed in a phosphate buffer solution over 21 days. Morselized bone grafts, synthetic bone cements Palacos and Copal, and synthetic bone grafts were tested as local carriers of vancomycin. The highest concentration approximately 670 mg/L of vancomycin was released from synthetic bone grafts Actifuse. Even after 21 days, the concentration of vancomycin was still above the minimum inhibitory concentration (MIC). The maximum concentration of vancomycin released in two experiments with human bone grafts exceeded 600 mg/L during the first day and was still above MIC level 21 days later when the experiment was concluded. By comparing the synthetic bone cements Palacos and Copal, Copal had the average maximum concentration of only 32.4 mg/L and Palacos 35.7 mg/L. The concentration of vancomycin fell below the MIC for vancomycin-resistant Staphylococcus aureus (VRSA) on the seventh day with Palacos and the ninth day with Copal. This study showed the insufficient concentration of released vancomycin from synthetic bone cements at the end of the experiment. For improvement of local prophylaxis, it would be beneficial to increase the amount of vancomycin in bone cements.
Similar content being viewed by others
References
Anagnostakos K, Schröder K (2012) Antibiotic-impregnated bone frafts in orthopaedic and trauma surgery: a systematic review of the literature. Int J Biomater 2012:1–9
Backes DW, Aboleneen HI, Simpson JA (1998) Quantitation of vancomycin ant its crystalline degradation products (CDP-1) in human serum by high performance liquid chromatography. J Pharm Biomed Anal 16(8):1281–1287
Brummett RE, Fox KE (1989) Vancomycin and erythromycin inducted hearing loss in humans. Antimicrob Agents Chemother 33(6):791–796
Buttaro M, Gimenez MI, Greco G, Barcan L, Piccaluga F (2005a) High active local levels of vancomycin without nephrotoxicity released from impacted bone allograft in 20 revision hip arthroplasties. Acta Orthop 76:336–340
Buttaro M, Pusso R, Piccaluga F (2005b) Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. J Bone Joint Surg (Br) 87(3):314–319
Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ (2007) Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am 89:871–882
Ghassempour A, Abdollahpour A, Tabar-Heydar K, Nabid MR, Mansouri S, Aboul-Enein HY (2005) Crystalline degradation products of vancomycin as a new clinical stationary phase for liquid chromatography. Chromatographia 61:151–155
Klekamp J, Dawson J, Haas DW, DeBoer D, Christie M (1999) The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effect and elution kinetics for use in joint arthroplasty. J Arthroplast 14(3):339–346
Kuehn KD, Ege W, Gopp U (2005) Acrylic bone cements: composition and properties. Orthop Clin North Am 36:17–28
Masri BA, Duncan CP, Beauchamp CP (1998) Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplast 13:331–338
Meani E, Romano C, Crosby L, Hofmann G (2007) Infection and local treatment in orthopedic surgery. Springer
Melicherčík P, Jahoda D, Nyč O, Klapková E, Barták V, Landor I et al (2012) Bone grafts as a vancomycin carrier for local therapy of resistant infections. Folia Microbiol 57(5):459–462
Melichercik P, Klapkova E, Landor I, Judl T, Sibek M, Jahoda D (2014) The effect of vancomycin degradation products in the topical treatment of osteomyelitis. Bratisl Lek Listy 115(12):796–799
Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE (1995) Bone toxicity of locally applied aminoglycosides. J Orthop Trauma 9:401–406
Nelson CL, Griffin FM, Harrison BH, Cooper RE (1992) In vitro elution characteristics of commercially and noncommercially prepared antibiotic PMMA beads. Clin Orthop Relat Res 284:303–309
Neut D, van de Belt H, van Horn JR, van der Mei HC, Busscher HJ (2003) The effect of mixing on gentamicin release from polymethylmethacrylate bone cements. Acta Orthop Scand 74(6):670–676
Perry CR, Davenport K, Vossen MK (1988) Local delivery of antibiotics via an implantable pump in the treatment of osteomyelitis. Clin Orthop Relat Res 226:222–230
Rybak MJ (2006) The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis 42:35–39
Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M et al (2009) Vancomycin therapeutic guidelines: a summary of consensuses commendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacistsp. Clin Infect Dis 49(3):325–327
Sattur AP, Lee JH, Song KB, Panda T, Kim CH, Rhee SK et al (2000) Analytical techniques for vancomycin – a review. Biotechnol Bioprocess Eng 5(3):153–158
Seligson D, Metha S, Voos K, Henry SL, Johnson JR (1992) The use of antibiotic-impregnated polymethylmethacrylate beads to prevent the evolution of localized infection. J Orthop Trauma 6:401–406
Somerville AL, Wright DH, Rotschafer JC (1999) Implication of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease. Pharmacotherapy 19:702–707
Suchý T, Šupová M, Klapková E, Horný L, Rýglová Š, Žaloudková M et al (2016) The sustainable release of vancomycin and its degradation products from nanostructured collagen/hydroxyapatite composite layers. J Pharm Sci 105:1288–1294
Wahling H, Dingeldein E (1980) Antibiotics and bone cements. Acta Orthop Scand 51:49–56
Winkler H, Janata O, Berger C, Wein W, Georgopoulos A (2000) In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemother 46:423–428
Winkler H, Stobier A, Kaudela K, Winter F, Menschik F (2008) One stage uncemented revisison of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg (Br) 90:1580–1584
Witso E, Persen L, Loseth K, Benum P, Bergh K (2000) Cancellous bone as an antibiotic carrier. Acta Orthop Scand 71:80–84
Acknowledgments
Supported by the Ministry of Health, Czech Republic—conceptual development of research organization, University Hospital Motol, Prague, Czech Republic 00064203. Special thanks to John Wilson and Ivana Kejvalova for English language revision.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was conducted according to the guidelines laid down in the 1964 Declaration of Helsinki and its later amendments.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Klapkova, E., Nescakova, M., Melichercik, P. et al. Vancomycin and its crystalline degradation products released from bone grafts and different types of bone cement. Folia Microbiol 65, 475–482 (2020). https://doi.org/10.1007/s12223-019-00752-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-019-00752-w